Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMBX Biosciences, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.74 | -$0.67 | -$0.70 |
| Q2 2026 | 1 | -$0.81 | -$0.81 | -$0.81 |
| Q3 2026 | 1 | -$0.85 | -$0.85 | -$0.85 |
| Q4 2026 | 1 | -$0.92 | -$0.92 | -$0.92 |
| Q1 2027 | 1 | -$1.08 | -$1.08 | -$1.08 |
| Q2 2027 | 1 | -$1.20 | -$1.20 | -$1.20 |
| Q3 2027 | 1 | -$1.31 | -$1.31 | -$1.31 |
| Q4 2027 | 1 | -$1.43 | -$1.43 | -$1.43 |
MBX Biosciences, Inc. Common Stock Earnings Date And Information
MBX Biosciences, Inc. Common Stock last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.63 earnings per share for the quarter, topping analysts' consensus estimates of $-0.73 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MBX Biosciences, Inc. Common Stock has generated $-2 earnings per share over the last year ($-1.85 diluted earnings per share) and currently has a price-to-earnings ratio of -13.45. MBX Biosciences, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 16th, 2026 based on prior year's report dates.
MBX Biosciences, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | -$0.73 | -$0.63 | 0.1 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$0.77 | -$0.58 | 0.19 | N/A | $0 |
| 05/12/2025 | Q1 2025 | -$0.81 | -$0.71 | 0.1 | N/A | $0 |
| 03/17/2025 | Q4 2024 | -$0.59 | -$0.47 | 0.12 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$2.72 | -$0.54 | 2.18 | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.48 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.37 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.28 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$0.32 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.23 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MBX Biosciences, Inc. Common Stock Earnings: FAQ's
MBX Biosciences, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 16th, 2026 based offlast year's report dates.
In the previous quarter, MBX Biosciences, Inc. Common Stock (:MBX) reported $-0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.73 by $0.1.
The conference call for MBX Biosciences, Inc. Common Stock's latest earnings report can be listened to online.
The conference call transcript for MBX Biosciences, Inc. Common Stock's latest earnings report can be read online.
MBX Biosciences, Inc. Common Stock (:MBX) has a recorded net income of $-61,922,000.MBX Biosciences, Inc. Common Stock has generated $-1.85 earnings per share over the last four quarters.
MBX Biosciences, Inc. Common Stock (:MBX) has a price-to-earnings ratio of -13.45 and price/earnings-to-growth ratio is 3.44.